other session 9

other session 9

University

7 Qs

quiz-placeholder

Similar activities

Malaysian CPG MDD

Malaysian CPG MDD

University

10 Qs

Singapore Healthcare

Singapore Healthcare

University

10 Qs

Wound Management

Wound Management

University

10 Qs

Day 4 Summary Quiz for Person Centred Care

Day 4 Summary Quiz for Person Centred Care

University

10 Qs

Foundations Chapter 3

Foundations Chapter 3

University

10 Qs

Virginia Henderson: Need Theory

Virginia Henderson: Need Theory

University

10 Qs

Geriatric Nursing

Geriatric Nursing

University

10 Qs

MMJ in NY

MMJ in NY

University

10 Qs

other session 9

other session 9

Assessment

Quiz

Other

University

Hard

Created by

Candice Bailey

FREE Resource

7 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which of the following is an adverse effect of epoetin alpha?

Hypertension

Hypotension

Hyperglycemia

Hypoglycemia

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the goal of using filgrastim (Neupogen)?

Maintain/Increase leukocyte counts (WBC’s)

Decrease blood pressure

Increase platelet counts

Reduce cholesterol levels

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the goal of pegfilgrastim (Neulasta)?

Decrease incidence of infection while patients are undergoing chemotherapy for nonmyeloid malignancies

Increase blood pressure

Decrease blood glucose levels

Increase cholesterol levels

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which of the following is NOT an adverse effect of epoetin alpha?

Hypertension

Cardiovascular events

Autoimmune pure red-cell aplasia (PRCA)

Hyperglycemia

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How is oprelvekin (Interleukin-11) administered?

Oral capsules

Intravenous injection

SQ injection

Topical application

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which of the following is NOT a nursing consideration for oprelvekin (Interleukin-11)?

Baseline VS

Baseline CBC

Patient Assessment

Dietary restrictions

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the primary therapeutic use of hydroxyurea (SCA: Droxia, cancer: Hydrea)?

Patients with sickle cell anemia

Patients receiving myelosuppressive chemotherapy

Patients with congestive heart failure

Patients with thrombocytopenia